Praxis Data Shows Breakthrough Seizure Control Across Epilepsies
BOSTON, MA — December 8, 2025 — Praxis Precision Medicines presented compelling new clinical results at the American Epilepsy...
clinical data
Advertisement
Omisirge Delivers Breakthrough Outcomes for Severe Aplastic Anemia
DUBLIN, IRELAND & LONDON, UK — December 8, 2025 — Ayrmid Ltd., parent company of Gamida Cell Inc., announced...
Mabwell’s 9MW3011 Achieves Positive Phase III Results in Moderate-to-Severe Plaque Psoriasis
SHANGHAI, CHINA – November 11, 2025 — Mabwell (688062.SH), an innovative biopharmaceutical company specializing in biologics for major diseases,...
Rhythm Pharmaceuticals Presents Four New Datasets at ObesityWeek® 2025
Boston, November 10, 2025 — Rhythm Pharmaceuticals, Inc. has announced the presentation of four pivotal datasets at ObesityWeek® 2025,...
Mirum Pharmaceuticals Presents New Data from LIVMARLI and Volixibat Programs at AASLD 2025
FOSTER CITY, Calif., November 7, 2025 — Mirum Pharmaceuticals, Inc., a biopharmaceutical company dedicated to transforming the lives of...
Advertisement
